ALBAN CARLOS 4
4 · SpringWorks Therapeutics, Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
ALBAN CARLOS
Director
Transactions
- Award
Common Stock
2024-05-16+4,095→ 18,801 total - Award
Stock Option (Right to Buy)
2024-05-16+12,216→ 12,216 totalExercise: $44.77Exp: 2034-05-16→ Common Stock (12,216 underlying)
Footnotes (3)
- [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (i) May 16, 2025 and (ii) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
- [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders.
- [F3]The options shall vest in full on the earlier of (i) May 16, 2025 and (ii) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.